Big movements in Tonix Pharmaceuticals stock price on Monday moving 42.49% between high and low

The Tonix Pharmaceuticals stock price gained 32.48% on the last trading day (Monday, 24th Mar 2025), rising from $23.03 to $30.51. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 42.49% from a day low at $26.55 to a day high of $37.83. The price has risen in 8 of the last 10 days and is up by 126.5% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 7 million shares were bought and sold for approximately $224.43 million.

On Jul 22, 2024, it was reported that Alliance Global Partners gave TNXP a "Buy" grade with a "hold" action.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $26.76, a level that may pose a second chance to hit a runner. According to fan-theory $41.22 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

The Tonix Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $20.00 and $12.20. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, March 03, 2025, and so far it has risen 313.41%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

On the downside, the stock finds support just below today's level from accumulated volume at $23.03.With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $11.28 between high and low, or 42.49%. For the last week, the stock has had daily average volatility of 29.84%.

The Tonix Pharmaceuticals stock is extremely overbought on RSI14 (83). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Tonix Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.